NCT02352558 2023-11-14A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic MalignanciesSumitomo Pharma America, Inc.Phase 1 Completed15 enrolled
NCT01323920 2017-05-30Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related DonorsDana-Farber Cancer InstitutePhase 2 Completed35 enrolled 9 charts